Nexalin Technology
NXL
4 hedge funds and large institutions have $11K invested in Nexalin Technology in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0.62% less ownership
Funds ownership: 0.79% → 0.17% (-0.62%)
33% less funds holding
Funds holding: 6 → 4 (-2)
76% less capital invested
Capital invested by funds: $45.5K → $11K (-$34.5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$22.9K |
| 2 |
Renaissance Technologies
New York
|
-$12K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$960 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3 |
NXL Hedge Fund Activity: Q2 2023 in Review
4 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q2 2023, worth a combined $11K — down 76% from $45.5K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NXL and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Two Sigma Securities, exiting entirely with an estimated $22.9K sold.
- 4 institutional investors held Nexalin Technology (NXL) as of Q2 2023, down from 6 in Q1 2023.
- Funds reported $11K of Nexalin Technology stock for Q2 2023, down 76% quarter-over-quarter.
- 0 funds opened new Nexalin Technology positions in Q2 2023 and 2 closed out, a net change of -2 holders.
- The largest Nexalin Technology seller in Q2 2023 was Two Sigma Securities, an estimated $22.9K sold.
Based on aggregated 13F filings for Q2 2023.